Work

Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group

Year: 2017
Type: article
Abstract: Chordomas are rare, malignant bone tumors of the skull-base and axial skeleton. Until recently, there was no consensus among experts regarding appropriate clinical management of chordoma, resulting in inconsistent care and suboptimal outcomes for many patients. To address this shortcoming, the European Society of Medical Oncology (ESMO) and the Chordoma Foundation, the global chordoma patient advocacy group, convened a multi-disciplinary group of chordoma specialists to define by consensus evidence-based best practices for the optimal approach to chordoma. In January 2015, the first recommendations of this group were published, covering the management of primary and metastatic chordomas. Additional evidence and further discussion were needed to develop recommendations about the management of local-regional failures. Thus, ESMO and CF convened a second consensus group meeting in November 2015 to address the treatment of locally relapsed chordoma. This meeting involved over 60 specialists from Europe, the United States and Japan with expertise in treatment of patients with chordoma. The consensus achieved during that meeting is the subject of the present publication and complements the recommendations of the first position paper.
Institutions: Fondazione IRCCS Istituto Nazionale dei Tumori, National Center for Oncological Hadrontherapy, European Institute of Oncology, Jichi Medical University, Jichi Medical University Saitama Medical Center, Saitama Medical Center, Saitama Medical University, Saitama Medical University, Institut Curie, University Hospital Carl Gustav Carus, Technische Universität Dresden, Centre Léon Bérard, Institut Gustave Roussy, Istituto Ortopedico Rizzoli, Ospedale Policlinico San Martino, Heidelberg University, Massachusetts General Hospital, Queen Elizabeth Hospital Birmingham, University College London Hospitals NHS Foundation Trust, University College London, Leiden University Medical Center, University of Brescia, Royal National Orthopaedic Hospital NHS Trust, Hôpital Lariboisière, Université Paris Diderot, University of Pittsburgh, Brown University, The Netherlands Cancer Institute, National Cancer Institute, Center for Cancer Research, Hospital Universitario Virgen del Rocío, University Medical Centre Mannheim, Harvard University, National Institute of Radiological Sciences, Institute for Radiological Science, Royal Orthopaedic Hospital, Royal Marsden NHS Foundation Trust, Institute of Cancer Research, National Cancer Centre Japan, Università degli Studi del Piemonte Orientale “Amedeo Avogadro”, Medical University of Graz, The Maria Sklodowska-Curie National Research Institute of Oncology, Istituto delle Scienze Neurologiche di Bologna, The University of Texas MD Anderson Cancer Center, Centre Oscar Lambret, NYU Langone Health, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center, Essen University Hospital, Mario Negri Institute for Pharmacological Research, Helios Hospital Berlin-Buch, Memorial Sloan Kettering Cancer Center, Paul Scherrer Institute, National Center for Spinal Disorders, Chordoma Foundation
Language: English
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $5,080
OpenAlex ID: W2586748258
FWCI: 19.17
Cites: 78
Cited by: 257
Related to: 10